S. Gartner (Barcelona, Spain), A. Smyth (Notthingham, United Kingdom)
Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF)
D. Smith, T. Kidd, K. Ramsay, C. Wainwright, S. Tai, S. Bell (Brisbane, Australia)
|   |
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
D. Bilton, R. Duff, N. Simmonds, J. Davies, W. Cookson, R. Wilson, E. Alton, P. Pantelidis, M. Moffatt (London, United Kingdom)
| |
Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis
M. Peetermans, P. Goeminne, K. De Boeck, L. Dupont (Leuven, Belgium)
| |
Full, shared and hybrid care for children and young people with cystic fibrosis
I. Doull, H. Evans (Cardiff, United Kingdom)
| |
Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis
C. O‘Brien, J. Bird, S. Moss (Newcastle, United Kingdom)
| |
Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis
F. Brinkmann, S. Junge, M. Ballmann (Germany)
| |
Aspergillus is now the dominant organism isolated from bronchoalveolar lavage in children with CF Children in north east England
N. Davidson, A. Blain, M. McKean, C. O‘Brien, S. Moss, D. Spencer (Newcastle upon Tyne, United Kingdom)
| |
Scedosporium species (Sspp) in patients with cystic fibrosis (CF): Implications for clinical practice
D. Smith, T. Kidd, K. Ramsay, S. Tai, S. Bell (Brisbane, Australia)
| |
Pharmacokinetics of oral voriconazole in adults with cystic fibrosis
I. Clifton, P. Whitaker, R. Metcalfe, M. Phillips, N. Shaw, D. Peckham (Leeds, United Kingdom)
| |
Inhaled dry powder mannitol in cystic fibrosis (CF): Microbiology results from the 6 month double-blind CF301 study
D. Bilton, P. Robinson, P. Cooper, J. Kolbe, C. G. Gallagher, H. Fox, B. Charlton (London, United Kingdom; Melbourne, Sydney, Australia; Auckland, New Zealand; Dublin, Ireland)
| |
The effect of rhDNase on ventilation inhomogeneity in patients with cystic fibrosis
R. Amin, P. Subbarao, W. Lou, A. Jabar, S. Balkovec, R. Jensen, S. Kerrigan, P. Gustafsson, F. Ratjen (Toronto, Canada; Skövde, Sweden)
| |
Lung clearance index (LCI) during the first years of life in children with CF
F. Aljassim, A. Lindblad, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
Short term variability of lung clearance index in CF and healthy controls
A. Lindblad, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
Monitoring of young children with CF
H. Tiddens, M. Bakker, E. Nieuwhof, C. van der Meijden, W. Hop (Rotterdam, Netherlands)
| |
The effect of nebulizer systems in inhaled tobramycin
P. Kroneberg, T. C. Topini, A. L. Valeri, B. Muellinger, G. Scheuch (Gemuenden/Wohra, Germany; Parma, Italy)
| |
Analysis of CFTR gene mutations in 24 Japanese individuals with cystic fibrosis
K. Yoshimura, C. Anzai, Y. Tsujikawa, M. Ejima, H. Tomoyasu (Tokyo, Japan)
| |
Sleep quality in cystic fibrosis
B. Fauroux, J. L. Pepin, C. Cracowski, R. Nove-Josserand, M. Murris-Espin, N. Stremler, T. Simon, P. Y. Boelle, P. R. Burgel (Paris, Grenoble, Lyon, Toulouse, Marseille, France)
| |
LSC 2010 Abstract: Neutrophil elastase plays a dual role in host lung defense against Pseudomonas aeruginosa infection
J. Wartelle, R. Benabid, N. Guyot, A. Belaaouaj (Reims, France)
| |